Suppr超能文献

偶氮甲碱、异恶唑、N-取代吡唑和含嘧啶的姜黄素衍生物:脲酶抑制作用及分子模拟研究

Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies.

作者信息

Ahmed Mahmood, Qadir Muhammad Abdul, Hameed Abdul, Arshad Muhammad Nadeem, Asiri Abdullah M, Muddassar Muhammad

机构信息

Institute of Chemistry, University of the Punjab, Lahore, 54590, Pakistan.

Institute of Chemistry, University of the Punjab, Lahore, 54590, Pakistan.

出版信息

Biochem Biophys Res Commun. 2017 Aug 19;490(2):434-440. doi: 10.1016/j.bbrc.2017.06.059. Epub 2017 Jun 13.

Abstract

Curcumin has shown large number of pharmacological properties against different phenotypes of various disease models. Different synthetic routes have been employed to develop its various derivatives for diverse biological functions. In this study, curcumin derived azomethine, isoxazole, pyrimidines and N-substituted pyrazoles were synthesized to investigate their urease enzyme inhibition. The structures of newly synthesized compounds were described by IR, MS, H NMR and C NMR spectral data. Urease enzyme inhibition was evaluated through in vitro assays in which compound 8b was found to be the most potent (IC = 2.44 ± 0.07 μM) among the tested compounds. The compounds with diazine ring system except the 4d showed better urease inhibition (IC = 11.43 ± 0.21-19.63 ± 0.28 μM) than the standard urease inhibitor thiourea (IC = 22.61 ± 0.23 μM). Similarly enzyme kinetics data revealed that compounds 3c-3e and 8b were competitive inhibitors with Ki values of 20.0, 19.87, 20.23 and 19.11 μM respectively while the compounds 4b, 4c and 4e were mixed type of inhibitors with Ki values 6.72, 19.69 and 6.72 μM respectively. Molecular docking studies were also performed to identify the plausible binding modes of the most active compounds.

摘要

姜黄素已显示出针对各种疾病模型不同表型的大量药理特性。人们采用了不同的合成路线来开发其各种衍生物以实现多样的生物学功能。在本研究中,合成了姜黄素衍生的甲亚胺、异恶唑、嘧啶和N-取代吡唑,以研究它们对脲酶的抑制作用。通过红外光谱、质谱、氢核磁共振谱和碳核磁共振谱数据对新合成化合物的结构进行了描述。通过体外试验评估脲酶抑制作用,结果发现化合物8b在测试化合物中活性最强(IC = 2.44 ± 0.07 μM)。除4d外,具有二嗪环系统的化合物显示出比标准脲酶抑制剂硫脲(IC = 22.61 ± 0.23 μM)更好的脲酶抑制作用(IC = 11.43 ± 0.21 - 19.63 ± 0.28 μM)。同样,酶动力学数据表明,化合物3c - 3e和8b是竞争性抑制剂,其Ki值分别为20.0、19.87、20.23和19.11 μM,而化合物4b、4c和4e是混合型抑制剂,其Ki值分别为6.72、19.69和6.72 μM。还进行了分子对接研究以确定最具活性化合物的可能结合模式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验